2025-12-24 - Analysis Report
Here's a comprehensive analysis of Schrodinger Inc. (SDGR) based on the provided data:

**0) Report Structure**

The report is structured as follows:

*   **Simple Numbers:** Presentation of raw data.
*   **Simple Analysis:** Interpretation of the presented data.

**1) Return Rate Comparison**

*   **Ticker:** SDGR
*   **Company Overview:** Schrodinger Inc. is a company focused on computational platform to accelerate drug discovery.
*   **SDGR Cumulative Return:** -55.96%
*   **S&P 500 (VOO) Cumulative Return:** 69.04%
*   **Divergence:**
    *   Max: 42.2
    *   Min: -127.1
    *   Current: -125.0
    *   Relative Divergence: 1.2

**Analysis:**

SDGR has significantly underperformed the S&P 500.  The current divergence is near the minimum of its historical range, indicating substantial underperformance compared to the market. The relative divergence of 1.2 suggests the current divergence is close to the worst it's been.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha   | Beta | Cap(B) |
|------------|--------|-------|---------|------|--------|
| 2020-2022  | -70.0% | 78.2% | -76.0% | 0.0 | 1.5    |
| 2021-2023  | -57.0% | 81.0% | -59.0% | -0.0 | 2.8    |
| 2022-2024  | 6.0%   | 81.0% | -14.0% | -0.0 | 1.5    |
| 2023-2025  | -4.0%  | 82.6% | -70.0% | -0.0 | 1.4    |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate is consistently negative for most periods, except for 2022-2024.
*   **MDD:** The Maximum Drawdown is very high, consistently over 78%, indicating significant risk and volatility.
*   **Alpha:** Negative Alpha values across all periods suggests underperformance relative to a benchmark.
*   **Beta:** Beta values around 0.0 suggest the stock has virtually no correlation to the market.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 17.66
*   **Last Market Data:** Price: 18.81, Previous Close: 19.39, Change: -2.99
*   **5-day SMA:** 17.68
*   **20-day SMA:** 17.57
*   **60-day SMA:** 19.04

**Analysis:**

The stock price is below its 60-day moving average, suggesting a recent downtrend. The 5-day and 20-day SMAs are very close to each other, indicating short-term stability after the decline. The last market data shows a recent negative change, confirming a recent downward movement in price.

**3) RSI, PPO, Market Risk Indicator, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 59.66
*   **PPO:** 0.38
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (58 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Divergence Change (20 days):** -0.7 (Negative - Short-term decline)
*   **Expected Return:** -5407.7% (negative)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is approaching overbought territory (above 70), suggesting a potential pullback, however not in extremely overbought territory..
*   The PPO is positive, suggesting the 20-day SMA is trending above the 60-day SMA (recent uptrend).
*   The negative change in relative divergence confirms a short-term decline.
*   The extremely negative expected return suggests the model predicts significant underperformance compared to S&P 500 if the current trends continues.
*   The hybrid signal indicates a strong buy signal based on the model, with no cash reserve recommended.

**4) Recent News & Significant Events**

*   **Positive Sentiment:**  Several articles highlight analyst upgrades and a strategic pivot toward the company's software platform.  The stock is reported as trading up.
*   **Strategic Shift:** The focus on the software platform is a key driver of positive sentiment.
*   **Options Activity:** Articles discuss unusual options activity, suggesting potential anticipation of price movement.
*   **Cautionary Note:** The Seeking Alpha article suggests a "complex story," implying inherent risks and uncertainties.

**Analysis:**

The news is largely positive, focusing on a strategic shift and analyst upgrades. This may be influencing the recent short term upward price movement. However, it's important to acknowledge that the longer term outlook remains uncertain and "complex".

**4-2) Analyst Opinions**

*   **Consensus:** Strong Buy
*   **Mean Rating:** 1.44 (Strong Buy)
*   **Number of Opinions:** 9
*   **Target Price (avg/high/low):** 27.22 / 33.00 / 18.00

**Analysis:**

Analyst sentiment is overwhelmingly positive, with a "Strong Buy" consensus and a mean rating close to the highest possible rating. The average target price represents a significant upside potential from the current price.

**5) Recent Earnings Analysis**

| 날짜        | EPS   | 매출       |
|-------------|-------|-------------|
| 2025-11-05 | -0.45 | 0.05 B$   |
| 2025-08-06 | -0.59 | 0.05 B$   |
| 2025-05-07 | -0.82 | 0.06 B$   |
| 2024-11-12 | -0.52 | 0.04 B$   |
| 2025-11-05 | -0.52 | 0.04 B$   |

**Analysis:**

The company consistently reports negative EPS (Earnings Per Share), indicating unprofitability. Revenue has fluctuated slightly but remains relatively consistent quarter to quarter.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30 | $0.05B | 51.61%        |
| 2025-06-30 | $0.05B | 47.77%        |
| 2025-03-31 | $0.06B | 52.26%        |
| 2024-12-31 | $0.09B | 72.61%        |
| 2024-09-30 | $0.04B | 50.24%        |

**Capital and Profitability:**

| Quarter      | Equity | ROE      |
|--------------|--------|----------|
| 2025-09-30 | $0.32B | -10.21% |
| 2025-06-30 | $0.34B | -12.59% |
| 2025-03-31 | $0.37B | -16.01% |
| 2024-12-31 | $0.42B | -9.54%  |
| 2024-09-30 | $0.45B | -8.49%  |

**Analysis:**

*   Revenue is relatively consistent but saw a significant jump in Q4 2024.
*   Profit margins are strong (above 47%), which is a positive sign despite the company's overall unprofitability.
*   Equity is decreasing over time.
*   ROE (Return on Equity) is consistently negative, reflecting the company's losses relative to its equity.

**7) Comprehensive Analysis (Summary)**

Schrodinger Inc. (SDGR) presents a mixed picture. While the company has strong profit margins, negative earning and negative ROE show it is still struggling with profitability. Analyst sentiment is strongly positive, driven by the strategic pivot toward its software platform.  However, the stock has significantly underperformed the S&P 500, with high volatility. Recent news suggests a potential short-term rebound, but the long-term outlook remains uncertain. The models suggests a strong buy and to invest 100% into the stock.

**In conclusion, SDGR is a high-risk, high-reward investment. The company's strategic shift and strong profit margins offer potential upside, but its current unprofitability and historical underperformance should be carefully considered.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.